Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Despite the need for novel, effective therapeutics for the COVID-19 pandemic, no curative regimen is yet available, therefore patients are forced to rely on supportive and nonspecific therapies. Some SARS-CoV-2 proteins, like the 3 C-like protease (3CLpro) or the major protease (Mpro), have been ide...

Full description

Bibliographic Details
Main Authors: Seyed Mohammad Reza Hashemian, Amirhossein Sheida, Mohammad Taghizadieh, Mohammad Yousef Memar, Michael R. Hamblin, Hossein Bannazadeh Baghi, Javid Sadri Nahand, Zatollah Asemi, Hamed Mirzaei
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Paxlovid
COVID-19
SARS-CoV-2
Nirmatrelvir
Ritonavir
3 C-like protease
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223001555

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223001555

Similar Items